BridgeBio Pharma
BBIO
#1444
Rank
โ‚น1.432 T
Marketcap
โ‚น7,354
Share price
0.17%
Change (1 day)
24.02%
Change (1 year)

P/S ratio for BridgeBio Pharma (BBIO)

P/S ratio as of November 2026 (TTM): 16.1

According to BridgeBio Pharma 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -9.22. At the end of 2026 the company had a P/S ratio of 13.9.

P/S ratio history for BridgeBio Pharma from 2019 to 2026

PS ratio at the end of each year

Year P/S ratio Change
202613.9-53.14%
202529.726.27%
202423.5-96.89%
20237555046.19%
202214.7-58.34%
202135.2-96.67%
2020> 1000889.85%
2019107

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
OPKO Health
OPK
2.49-84.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
92.5 473.41%๐Ÿ‡บ๐Ÿ‡ธ USA